BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 8480725)

  • 1. Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A.
    Hanauer SB; Smith MB
    Am J Gastroenterol; 1993 May; 88(5):646-9. PubMed ID: 8480725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T; Göke B; Sackmann M
    Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ; Sandborn WJ; Tremaine WJ
    Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease.
    Hinterleitner TA; Petritsch W; Aichbichler B; Fickert P; Ranner G; Krejs GJ
    Z Gastroenterol; 1997 Aug; 35(8):603-8. PubMed ID: 9297775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin treatment of anal and perianal lesions associated with Crohn's disease.
    Cat H; Sophani I; Lemann M; Modiglani R; Solue JC
    Turk J Gastroenterol; 2003 Jun; 14(2):121-7. PubMed ID: 14614639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment with chimeric monoclonal antitumor necrosis factor (infliximab) of patients with active steroid-dependent/resistant Crohn's disease and fistulas].
    Martorana G; Casà A; Oliva L; Orlando A; Cottone M
    Recenti Prog Med; 2001; 92(7-8):451-5. PubMed ID: 11475786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronidazole therapy for Crohn's disease and associated fistulae.
    Jakobovits J; Schuster MM
    Am J Gastroenterol; 1984 Jul; 79(7):533-40. PubMed ID: 6741906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease.
    Sandborn WJ
    Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
    Gaertner WB; Decanini A; Mellgren A; Lowry AC; Goldberg SM; Madoff RD; Spencer MP
    Dis Colon Rectum; 2007 Nov; 50(11):1754-60. PubMed ID: 17899271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children.
    Mahdi G; Israel DM; Hassall E
    Am J Gastroenterol; 1996 Jul; 91(7):1355-9. PubMed ID: 8677994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease.
    Van Assche G; Vanbeckevoort D; Bielen D; Coremans G; Aerden I; Noman M; D'Hoore A; Penninckx F; Marchal G; Cornillie F; Rutgeerts P
    Am J Gastroenterol; 2003 Feb; 98(2):332-9. PubMed ID: 12591051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: The medical treatment of Crohn's perianal fistulas.
    Schwartz DA; Herdman CR
    Aliment Pharmacol Ther; 2004 May; 19(9):953-67. PubMed ID: 15113362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab in the surgical management of complex fistulating anal Crohn's disease.
    Talbot C; Sagar PM; Johnston MJ; Finan PJ; Burke D
    Colorectal Dis; 2005 Mar; 7(2):164-8. PubMed ID: 15720356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report.
    van der Hagen SJ; Baeten CG; Soeters PB; Russel MG; Beets-Tan RG; van Gemert WG
    Dis Colon Rectum; 2005 Apr; 48(4):758-67. PubMed ID: 15750797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
    Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
    Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of fistulas in patients with Crohn's disease: antibiotic to antibody.
    Paré P
    Can J Gastroenterol; 2001 Nov; 15(11):751-6. PubMed ID: 11727005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endorectal advancement flap in perianal Crohn's disease.
    Joo JS; Weiss EG; Nogueras JJ; Wexner SD
    Am Surg; 1998 Feb; 64(2):147-50. PubMed ID: 9486887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endorectal advancement flap: are there predictors of failure?
    Mizrahi N; Wexner SD; Zmora O; Da Silva G; Efron J; Weiss EG; Vernava AM; Nogueras JJ
    Dis Colon Rectum; 2002 Dec; 45(12):1616-21. PubMed ID: 12473884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.